Medical Doctor Program year 2020 Source: CMS Open Payments, 2026 publication

Seth Gale

Neurology Boston, MA Medical Doctor

NPI 1194988659 CMS profile 711112

Center For Brain/Mind Medicine, 60 Fenwood Road, 9Th Floor 9016-I, Boston, MA 02115

Open in the dashboard

General payments

$1,980

2 records reported · program year 2020

Research payments

$0

Paid to them · None reported · program year 2020

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$2,908,281 paid to institutions, not to them · program years 2019–2025

Through program year 2020, Seth Gale of Boston, MA is reported in the CMS Open Payments database as having received $1,980 across 2 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $2,908,281 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 54th percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2020 General $1,980 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Seth Gale
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Seth Gale were reported at $0. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Seth Gale Neurology median Middle half National median
2019 $0 $474 $118–$2,177 $163
2020 $1,980 $367 $82–$2,309 $114
2021 $0 $438 $104–$2,547 $132
2022 $0 $442 $103–$2,388 $149
2023 $0 $464 $119–$2,312 $160
2024 $0 $468 $119–$2,323 $164
2025 $0 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program year 2020
  1. Biogen, Inc. $1,980 2 payments

Every payment, record by record

What the payments were for General payments · program year 2020
  1. Consulting Fee $1,050 1 payment
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $930 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 17 drugs

Part D claims

567

Median for Neurology: 833

Drug cost

$35,699

Median for Neurology: $202,670

Branded share of claims

12.3%

Median for Neurology: 25.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Rivastigmine Generic 50 $16,441
Memantine Hcl Generic 53 $3,937
Rivastigmine Rivastigmine Tartrate Brand 27 $3,833
Galantamine Er Galantamine Hbr Brand 12 $2,266
Methylphenidate Er Methylphenidate Hcl Brand 13 $1,716
Ramelteon Generic 11 $1,621
Escitalopram Oxalate Generic 86 $1,227
Donepezil Hcl Generic 90 $1,107
Quetiapine Fumarate Generic 25 $644
Trazodone Hcl Generic 49 $535

The 10 drugs with the highest cost, of 17 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,695 Part D prescribers listed as Neurology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 7 billing codes

Paid by Medicare

$36,733

Medicare's payments for the services billed

Medicare patients

242

Average age 77

Services billed

378

122 women, 120 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 69%
Alzheimer's or dementia 69%
Arthritis 46%
Depression 40%
Ischemic heart disease 26%
Chronic kidney disease 24%
Cancer 23%
Diabetes 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

2 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2020

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record